Publications found:
36,576
Sort by:
Alcoholic Hepatitis Treatment Market - 2024-2031
US$ 3,400.00
The Alcoholic Hepatitis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to de...
November 2024
55 pages
Hyaluronidase Market - 2024-2031
US$ 3,400.00
Hyaluronidase Marketis is growing with a CAGR of 8.00% during the forecast period 2026-2035. The Hyaluronidase Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seaso...
November 2024
39 pages
Epidermolysis Bullosa Therapeutics Market - 2024-2031
US$ 3,400.00
Epidermolysis Bullosa Therapeutics Marketis is growing with a CAGR of 7.00% during the forecast period 2026-2035. The Epidermolysis Bullosa Therapeutics Market emerges as a key focus in DataM Intellig...
November 2024
60 pages
Myelodysplastic Syndrome (MDS) Treatment Market - 2024-2031
US$ 3,400.00
Myelodysplastic Syndrome (MDS) Treatment Market reached US$ 6,059.5 million in 2031 and, growing with a CAGR of 9.10% during the forecast period 2031-2035. The Myelodysplastic Syndrome (MDS) Treatment...
November 2024
66 pages
Refractory Epilepsy Treatment Market - 2024-2031
US$ 3,400.00
Refractory Epilepsy Treatment Market reached US$ 3.97 billion in 2023 and is expected to reach US$ 5.78 billion by 2031, growing with a CAGR of 4.80% during the forecast period 2026-2031. The Refracto...
November 2024
55 pages
Interstitial lung disease (ILD) Market - 2024-2031
US$ 3,400.00
Interstitial lung disease (ILD) Marketis is growing with a CAGR of 6.10% during the forecast period 2026-2035. The Interstitial lung disease (ILD) Market emerges as a key focus in DataM Intelligence l...
November 2024
57 pages
Prescription Drugs Markets in China
US$ 4,000.00
China's demand for Prescription Drugs has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
October 2024
217 pages
Prescription Drugs Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Prescription Drugs industry forecasts. In the two past decades, the ... -term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...
October 2024
93 pages
Prescription Drugs Companies in China
US$ 1,800.00
This study focuses on China’s Prescription Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
October 2024
73 pages
In Vitro Toxicity Testing Market - 2024-2031
US$ 3,400.00
The In Vitro Toxicity Testing Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to delive...
October 2024
51 pages
Dyspepsia Drug Market - 2024-2031
US$ 3,400.00
The Dyspepsia Drug Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalle...
October 2024
40 pages
Klinefelter Syndrome Treatment Market - 2024-2031
US$ 3,400.00
The Klinefelter Syndrome Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to d...
October 2024
56 pages
Europe Cancer Cachexia Market - 2024-2031
US$ 2,499.00
Europe Cancer Cachexia Market reached US$ 618.75 million in 2022 and is expected to reach US$ 897.58 million by 2031, growing with a CAGR of 4.80% during the forecast period 2026-2031. The Europe Canc...
October 2024
48 pages
Schistosomiasis Drugs Market - 2024-2031
US$ 3,400.00
Schistosomiasis Drugs Marketis is growing with a CAGR of 3.80% during the forecast period 2026-2035. The Schistosomiasis Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analy...
October 2024
47 pages
Pharmaceutical Drying Equipment Market by Type (Freeze, Spray, Vacuum, Fluidized Bed), Scale of Operation (Industrial-scale, Pilot-scale, Lab-scale), End User (Pharmaceutical Companies, CDMOs, Research Universities) - Global Forecast to 2029
US$ 2,970.00
The global Pharmaceutical Drying Equipment market is projected to reach USD 8.18 billion by 2029 from USD 5.80 billion in 2024, at a CAGR of 7.1% during the forecast period. This is due to growing pre...
October 2024
227 pages
Adenoid Cystic Carcinoma Market - 2024-2031
US$ 3,400.00
Adenoid Cystic Carcinoma Marketis is growing with a CAGR of 5.60% during the forecast period 2026-2035. The Adenoid Cystic Carcinoma Market emerges as a key focus in DataM Intelligence latest in-depth...
October 2024
50 pages
Atherosclerosis Drugs Market - 2024-2031
US$ 3,400.00
Atherosclerosis Drugs Market reached US$ 26.4 billion in 2023 and is expected to reach US$ 32.5 billion by 2031, growing with a CAGR of 2.60% during the forecast period 2026-2031. The Atherosclerosis...
October 2024
47 pages
T-cell-lymphoma Market - 2024-2031
US$ 3,400.00
T-cell-lymphoma Market reached USD 2,787.8 million in 2031 and, growing with a CAGR of 8.40% during the forecast period 2031-2035. The T-cell-lymphoma Market emerges as a key focus in DataM Intelligen...
October 2024
41 pages
Alcohol Use Disorder Treatment Market - 2024-2031
US$ 3,400.00
The Alcohol Use Disorder Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to d...
October 2024
56 pages
Peripheral Neuropathy Market - 2024-2031
US$ 3,400.00
Peripheral Neuropathy Marketis is growing with a CAGR of 4.20% during the forecast period 2026-2035. The Peripheral Neuropathy Market emerges as a key focus in DataM Intelligence latest in-depth analy...
October 2024
47 pages
Adrenocortical Hormones API Market - 2024-2031
US$ 3,400.00
The Adrenocortical Hormones API Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deli...
October 2024
53 pages
Lyophilized Injectable Drugs Market - 2024-2031
US$ 3,400.00
The Lyophilized Injectable Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to del...
October 2024
54 pages
Familial Hypercholesterolemia Treatment Market - 2024-2031
US$ 3,400.00
The Familial Hypercholesterolemia Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic fores...
October 2024
65 pages
Active Pharmaceutical Ingredients: Global Markets
US$ 4,650.00
... (Active Pharmaceutical Ingredients: Global Markets to 2022) covers an overview of the pharmaceutical industry landscape and active pharmaceutical ingredients (API), along with the current trends and dynamics shaping the API market landscape. API sourcing ...
October 2024
119 pages
Angiotensin II Receptor Blockers Market - 2024-2031
US$ 3,400.00
The Angiotensin II Receptor Blockers Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to...
October 2024
58 pages
Adrenoleukodystrophy Treatment Market - 2024-2031
US$ 3,400.00
Adrenoleukodystrophy Treatment Market reached US$ 323.36 million in 2023 and is expected to reach US$ 673.03 million by 2031, growing with a CAGR of 9.60% during the forecast period 2026-2031. The Adr...
October 2024
56 pages
Primary Peritoneal Cancer Therapeutics Market - 2024-2031
US$ 3,400.00
The Primary Peritoneal Cancer Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresi...
October 2024
64 pages
Juvenile Dermatomyositis Treatment Market - 2024-2031
US$ 3,400.00
Juvenile Dermatomyositis Treatment Market reached US$ 71.15 million in 2023 and is expected to reach US$ 101.93 million by 2031, growing with a CAGR of 4.60% during the forecast period 2026-2031. The...
October 2024
60 pages
Neurodegenerative Disease Market - 2024-2031
US$ 3,400.00
Neurodegenerative Disease Marketis is growing with a CAGR of 7.45% during the forecast period 2026-2035. The Neurodegenerative Disease Market emerges as a key focus in DataM Intelligence latest in-dep...
October 2024
51 pages
Hodgkin’s Lymphoma Market - 2024-2031
US$ 3,400.00
Hodgkin’s Lymphoma Market reached US$ 2.1 billion in 2031 and, growing with a CAGR of 9.80% during the forecast period 2031-2035. The Hodgkin’s Lymphoma Market emerges as a key focus in DataM Intellig...
October 2024
44 pages
Bronchiectasis Drugs Market - 2024-2031
US$ 3,400.00
The Bronchiectasis Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
October 2024
46 pages
Neuromyelitis Optica (Devic's Syndrome) Market - 2024-2031
US$ 3,400.00
Neuromyelitis Optica (Devic's Syndrome) Marketis is growing with a CAGR of 4.80% during the forecast period 2026-2035. The Neuromyelitis Optica (Devic's Syndrome) Market emerges as a key focus in Data...
October 2024
65 pages
Acute Lymphocytic Leukemia Therapeutics Market - 2024-2031
US$ 3,400.00
Acute Lymphocytic Leukemia Therapeutics Market reached US$ 4.5 billion in 2031 and, growing with a CAGR of 5.80% during the forecast period 2031-2035. The Acute Lymphocytic Leukemia Therapeutics Marke...
October 2024
65 pages
Malignant Pleural Mesothelioma Treatment Market - 2024-2031
US$ 3,400.00
Malignant Pleural Mesothelioma Treatment Market reached US$ 387.73 million in 2023 and is expected to reach US$ 649.83 million by 2031, growing with a CAGR of 6.80% during the forecast period 2026-203...
October 2024
66 pages
Bronchial Spasm Market - 2024-2031
US$ 3,400.00
Bronchial Spasm Market reached US$ 424.36 million in 2023 and is expected to reach US$ 650.05 million by 2031, growing with a CAGR of 5.60% during the forecast period 2026-2031. The Bronchial Spasm Ma...
October 2024
41 pages
Global Heart Failure Therapeutics Market Size Study, by Treatment (Medical Devices, Medicines, Surgery), by Type (Diagnosis, Prognosis), by Stage (Stage A, Stage B, Stage C, Stage D), by End User (Clinic, Hospital, Medical Research Organization), and Regional Forecasts 2022-2032
US$ 3,000.00
The Global Heart Failure Therapeutics Market is valued at approximately USD 23.98 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.46% over the forecast period 202...
October 2024
285 pages
Hypertrophic Cardiomyopathy Therapeutics Market - 2024-2031
US$ 3,400.00
The Hypertrophic Cardiomyopathy Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic fore...
October 2024
66 pages
India Tapentadol Market - 2024-2031
US$ 1,899.00
India Tapentadol Market reached US$ 28.24 million in 2023 and is expected to reach US$ 45.55 million by 2031, growing with a CAGR of 6.20% during the forecast period 2026-2031. The India Tapentadol Ma...
October 2024
42 pages
Pneumonia Therapeutics Market - 2024-2031
US$ 3,400.00
Pneumonia Therapeutics Marketis is growing with a CAGR of 7.50% during the forecast period 2026-2035. The Pneumonia Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth ana...
October 2024
48 pages
Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2029
US$ 2,970.00
... for the growth of the clinical trial imaging market. Developing markets in Asia such as Japan, China, and India are lucrative markets for clinical trial imaging. Asia is expected to grow at the ... in the clinical trial imaging market Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for clinical trial imaging products across various regions Market Diversification: Exhaustive ...
October 2024
249 pages
Asia Pacific Liver Disease Treatment Market - 2024-2031
US$ 2,499.00
Asia Pacific Liver Disease Treatment Market reached US$ 3.84 billion in 2023 and is expected to reach US$ 5.83 billion by 2031, growing with a CAGR of 5.50% during the forecast period 2026-2031. The A...
October 2024
62 pages
